Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HSK3486 and Voriconazole DDI Study
NCT04145583Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Dec 2019
- Primary completion
- Jan 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cipepofol in Anesthesia and sedation (2 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Peak Concentration, Area Under the Concentration-Time Curve from time zero to last measurable concentration and 1 more. Started Dec 2019; status: completed.
02
Drugs
cipepofol
03
Conditions
Anesthesiasedation
Beyond the preview
Go deeper on NCT04145583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145583.